Frank Landolt

Frank Landolt (MSc, LL.M, EPA) - Chief Counsel, Intellectual Property and Legal, is a Dutch and European patent attorney and transactional lawyer. Prior to joining Confo in 2019, Frank was a member of the management team at Ablynx from 2004 to 2018, where he was responsible for Ablynx’s IP strategy and securing its strong patent estate, and where he was also involved in negotiating Ablynx’s various partnerships with leading pharma companies. Frank started his career in private practice in the Netherlands, where his clients included major pharmaceutical companies, as well as some of the top biotech companies and research institutions in the Netherlands. From 2000 to 2004, he was Director of IP and Legal at another Belgian biotech company, Devgen, that was acquired by Syngenta in 2012. Frank holds degrees in chemistry (Leiden University), civil law (Leiden University) and business law (University of Antwerp), and was named as one of Managing IP’s ‘Corporate IP stars’ for four years in a row (2015-2018).​